Charles River Laboratories (CRL): HHS awarded $5.31M

$5.31M

committed so far

$43.3M

maximum it could reach

Signed

Feb 28, 2026

Updated

Aug 31, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 22, 2025InsiderOfficer sold ~$65K of CRL shares in the open market
2. Jan 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 8, 2026, the Board of Directors (the “Board”) of Charles River Laboratories International, Inc. (the “Company”) announced a leadership transition plan.”
3. Jan 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
4. Jan 20, 2026Federal contract · $1.9M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $1.92M obligated to date
5. Feb 10, 20265% stakeWellington Management Group LLP reported a passive stake (13G) of 3.6%
6. Feb 12, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 5.5%
7. Feb 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 18, 2026, the Company announced the appointment of Glenn Coleman as its Corporate Executive Vice President and Chief Financial Officer. Mr. Coleman will join the company with a tentative start date of April 6, 2026.”
8. Feb 18, 2026Company filing · Form 8-K · ResultsReported its results
9. Feb 25, 2026Federal contract · $936K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $936K obligated to date

What came next

1. Mar 3, 2026Insider · First insider buy since Feb 2025Officer purchased ~$4.4K of CRL shares in the open market
2. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
3. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.4%
4. May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, Charles River Laboratories International, Inc. (the “Company”) held its 2026 annual meeting of shareholders (the “Annual Meeting”). As further discussed below, at the Annual Meeting, the shareholders of the Company approved the Company’s 2026 Long-Term Incentive Plan (the “2026 Incentive Plan”).”
5. May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 7.0%
6. May 6, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 4.9%
7. May 7, 2026Company filing · Form 8-K · ResultsReported its results
8. Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
9. Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for Charles River Laboratories

For Charles River Laboratories, OQRO holds 9 insider filings (SEC Form 4 or Form 144) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.

How this filing works

• Contract ceiling vs obligated amount

Other disclosures at Charles River Laboratories

• SEC Form 4Oct 26, 2026
• SEC Form 4Oct 23, 2026
• SEC Form 144Oct 22, 2026
• SEC Form 144Oct 21, 2026
• SEC Form 4Oct 8, 2026
• SEC Form 144Oct 5, 2026

Everything OQRO holds on this company is on its CRL page.